X0306 4/A 2013-01-15 2013-02-01 0 0001418862 Kior Inc KIOR 0001523900 BIOeCON B.V. HOGEBRINKERWEG 15 E HOEVELAKEN P7 3871 KM NETHERLANDS 0 0 1 0 0001525002 BIOeCON Holding B.V. HOGEBRINKERWEG 15E HOEVLAKEN P7 00000 NETHERLANDS 0 0 1 0 0001524671 BIOeCON International Holding N.V. 14 KAYA WFG (JOMBI) MENSING WILLEMSTAD P8 0000000000 NETHERLANDS ANTILLES 0 0 1 0 Class A Common Stock 2013-01-15 4 J 0 1000000 A 1000000 D Class B Common Stock 2013-01-15 4 J 0 1000000 D Class A Common Stock 1000000 5353576 D One share of Class B Common Stock is convertible into one share of Class A Common Stock at any time, at the option of the holder, and all shares of Class B Common Stock may be converted upon the affirmative vote of holders of at least a majority of the shares of Class B Common Stock outstanding. In addition, each share of Class B Common Stock will automatically convert into one share of Class A Common Stock upon any transfer, whether or not for value, subject to certain exceptions. On January 15, 2013, BIOeCON B.V. effected a conversion of 1,000,000 shares of Class B Common Stock which resulted in BIOeCON B.V. acquiring 1,000,000 shares of Class A Common Stock. The reporting persons are BIOeCON B.V. and BIOeCON Holding B.V., each a Dutch corporation with an address of Hogebrinkerweg 15 e, 3871 KM Hoevelaken, The Netherlands and BIOeCON International Holding N.V., a Curacao, Netherlands Antilles corporation, with an address of 14 Kaya W.F.G. (Jombi) Mensing, Curacao, Netherlands Antilles. The Class B Common Stock securities reported are beneficially owned indirectly by BIOeCON Holding B.V. in its capacity as the controlling shareholder of BIOeCON B.V. and beneficially owned indirectly by BIOeCON Holding International Holding N.V. in its capacity as the controlling shareholder of BIOeCON Holding B.V. * This Form 4/A is being filed solely to correct a ministerial error in the filing process which resulted in the transaction being incorrectly marked as an acquisition in Column 5 instead of a disposition on the original Form 4. Each of the Reporting Owners identified in this statement disclaims beneficial ownership of the securities described in this statement, except to the extent of their individual respective pecuniary interest in such securities. The filing of this statement shall not be deemed an admission that any of the Reporting Owners identified in this statement are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any securities specified in this statement other than those directly beneficially owned by them. BIOeCON B.V., By: BIOeCON Holding B.V., Managing Director, By: /s/ B. Bekkering and /s/ O.B. de Haseth 2013-03-15 BIOeCON Holding B.V., By: BIOeCON International Holding N.V., Managing Director, By: /s/ B. Bekkering and /s/ O.B. de Haseth 2013-03-15 BIOeCON International Holding N.V., By: Orangefield Trust (Caribbean) N.V., Managing Director, By: /s/ B. Bekkering and By: /s/ O.B. de Haseth, Managing Director 2013-03-15